© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
Technology
AI Innovations Amid COVID-19
July 03, 2020
Drug Topics interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence (AI) can mitigate challenges posed by the COVID-19 pandemic.
NACDS: Electronic Prescriptions for Controlled Substances Should be Mandatory
July 02, 2020
NACDS is urging the Drug Enforcement Administration to make electronic prescriptions for controlled substances mandatory.
New Machine Learning Tool Can Predict Adverse Drug Effects
June 29, 2020
A new computer algorithm might be the next step toward accurate prediction of adverse drug reactions.
FDA Clears First Prescription Game-Based Treatment Device for Children With ADHD
June 17, 2020
EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.
FDA OKs FreeStyle Libre 2 System for Adults and Children With Diabetes
June 15, 2020
Abbott’s FreeStyle Libre 2 is an integrated continuous glucose monitoring system for adults and children ages 4 and older with diabetes.
ADA 2020: FreeStyle Libre System Use Decreases Diabetic Ketoacidosis Rates
June 13, 2020
New findings from a study presented at the ADA’s 80th Scientific Sessions showed a dramatic drop in diabetic ketoacidosis hospitalizations in patients who used the FreeStyle Libre system
Technology-Enhanced Insulin Education by Pharmacists Prior to Hospital Discharge Boosts Patient Confidence
June 13, 2020
A poster presented at ADA’s 80th Scientific Sessions examines the effects of interactive pharmacist insulin teaching for patients with diabetes prior to hospital discharge.
Telehealth Program Enhances Engagement, Glycemic Control in Rural Patients With Diabetes
June 13, 2020
Presented during ADA’s 80th Scientific Sessions, results from an analysis of a 6-month telehealth intervention showed sustained improvements in glycemic control in patients with diabetes.
New Apps Tap Into Unmet Need for COVID-19 Testing in the US
June 11, 2020
Syndromic surveillance apps may be key in providing solutions to limitations on current COVID-19 case projection data collection efforts.
COVID-19 and Telemedicine: A Conversation
May 26, 2020
In an interview with Drug Topics®, Richard Scholz, chief strategy officer of ERxDirect, explained the prominence of telemedicine during the COVID-19 pandemic and the lasting implications of new technologies during unprecedented times.